Home Healthcare Pharmaceuticals Sirolimus Market

Sirolimus Market Size, Share & Trends Analysis Report By Strength (5mg, 1mg, 2mg, 1mg/mL), By Application (Organ Transplant Rejection, Sirolimus Catheter Device, Sirolimus Coated Balloons, Others), By Drug Class (mTOR Inhibitors, Selective Immunosuppressants), By Dosage (Injection, Tablet, Others), By Route of Administration (Oral, Intravenous, Others), By End-Users (Hospitals, Specialty Clinics, Homecare, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR5722DR | Pages: 155
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Sirolimus Market Size Analysis
    1. Introduction
    2. Sirolimus Market Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
      1. 5mg
      2. 1mg
      3. 2mg
      4. 1mg/mL
    3. Sirolimus Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Organ Transplant Rejection
      2. Sirolimus Catheter Device
      3. Sirolimus Coated Balloons
      4. Others
    4. Sirolimus Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. mTOR Inhibitors
      2. Selective Immunosuppressants
    5. Sirolimus Market Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
      1. Injection
      2. Tablet
      3. Others
    6. Sirolimus Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous
      3. Others
    7. Sirolimus Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Specialty Clinics
      3. Homecare
      4. Others
  7. North America Sirolimus Market Size Analysis
    1. Introduction
    2. Sirolimus Market Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
      1. 5mg
      2. 1mg
      3. 2mg
      4. 1mg/mL
    3. Sirolimus Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Organ Transplant Rejection
      2. Sirolimus Catheter Device
      3. Sirolimus Coated Balloons
      4. Others
    4. Sirolimus Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. mTOR Inhibitors
      2. Selective Immunosuppressants
    5. Sirolimus Market Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
      1. Injection
      2. Tablet
      3. Others
    6. Sirolimus Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous
      3. Others
    7. Sirolimus Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Specialty Clinics
      3. Homecare
      4. Others
    8. U.S.
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    9. Canada
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
  8. Europe Sirolimus Market Size Analysis
    1. Introduction
    2. Sirolimus Market Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
      1. 5mg
      2. 1mg
      3. 2mg
      4. 1mg/mL
    3. Sirolimus Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Organ Transplant Rejection
      2. Sirolimus Catheter Device
      3. Sirolimus Coated Balloons
      4. Others
    4. Sirolimus Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. mTOR Inhibitors
      2. Selective Immunosuppressants
    5. Sirolimus Market Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
      1. Injection
      2. Tablet
      3. Others
    6. Sirolimus Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous
      3. Others
    7. Sirolimus Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Specialty Clinics
      3. Homecare
      4. Others
    8. U.K.
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    9. Germany
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    10. France
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    11. Spain
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    12. Italy
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    13. Russia
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    14. Nordic
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    15. Benelux
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    16. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
  9. APAC Sirolimus Market Size Analysis
    1. Introduction
    2. Sirolimus Market Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
      1. 5mg
      2. 1mg
      3. 2mg
      4. 1mg/mL
    3. Sirolimus Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Organ Transplant Rejection
      2. Sirolimus Catheter Device
      3. Sirolimus Coated Balloons
      4. Others
    4. Sirolimus Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. mTOR Inhibitors
      2. Selective Immunosuppressants
    5. Sirolimus Market Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
      1. Injection
      2. Tablet
      3. Others
    6. Sirolimus Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous
      3. Others
    7. Sirolimus Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Specialty Clinics
      3. Homecare
      4. Others
    8. China
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    9. Korea
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    10. Japan
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    11. India
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    12. Australia
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    13. Singapore
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    14. Taiwan
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    15. South East Asia
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    16. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
  10. Middle East and Africa Sirolimus Market Size Analysis
    1. Introduction
    2. Sirolimus Market Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
      1. 5mg
      2. 1mg
      3. 2mg
      4. 1mg/mL
    3. Sirolimus Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Organ Transplant Rejection
      2. Sirolimus Catheter Device
      3. Sirolimus Coated Balloons
      4. Others
    4. Sirolimus Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. mTOR Inhibitors
      2. Selective Immunosuppressants
    5. Sirolimus Market Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
      1. Injection
      2. Tablet
      3. Others
    6. Sirolimus Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous
      3. Others
    7. Sirolimus Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Specialty Clinics
      3. Homecare
      4. Others
    8. UAE
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    9. Turkey
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    10. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    11. South Africa
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    12. Egypt
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    13. Nigeria
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    14. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
  11. LATAM Sirolimus Market Size Analysis
    1. Introduction
    2. Sirolimus Market Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
      1. 5mg
      2. 1mg
      3. 2mg
      4. 1mg/mL
    3. Sirolimus Market Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
      1. Organ Transplant Rejection
      2. Sirolimus Catheter Device
      3. Sirolimus Coated Balloons
      4. Others
    4. Sirolimus Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. mTOR Inhibitors
      2. Selective Immunosuppressants
    5. Sirolimus Market Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
      1. Injection
      2. Tablet
      3. Others
    6. Sirolimus Market Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
      1. Oral
      2. Intravenous
      3. Others
    7. Sirolimus Market Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Specialty Clinics
      3. Homecare
      4. Others
    8. Brazil
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    9. Mexico
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    10. Argentina
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    11. Chile
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    12. Colombia
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
    13. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Strength 2022-2034 (USD MILLION/ Units)
        1. 5mg
        2. 1mg
        3. 2mg
        4. 1mg/mL
      3. Market Size & Forecast By Application 2022-2034 (USD MILLION/ Units)
        1. Organ Transplant Rejection
        2. Sirolimus Catheter Device
        3. Sirolimus Coated Balloons
        4. Others
      4. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. mTOR Inhibitors
        2. Selective Immunosuppressants
      5. Market Size & Forecast By Dosage 2022-2034 (USD MILLION/ Units)
        1. Injection
        2. Tablet
        3. Others
      6. Market Size & Forecast By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Intravenous
        3. Others
      7. Market Size & Forecast By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Specialty Clinics
        3. Homecare
        4. Others
  12. Competitive Landscape
    1. Sirolimus Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Accord Healthcare (US)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Apotex Inc. (Canada)
    3. and Amneal Pharmaceuticals LLC. (US)
    4. Pfizer Inc. (US)
    5. Zydus Cadila (India)
    6. Dr. Reddy's Laboratories Ltd. (India)
    7. Torrent Pharmaceuticals Ltd. (India)
    8. Biocon (India)
    9. Concept Medical (US)
    10. Intas Pharmaceuticals Ltd (India)
    11. Concord Biotech (India)
    12. Livzon (China)
    13. Actiza Pharmaceutical Private Limited (India)
    14. Tiefenbacher API + Ingredients GmbH & Co. KG (Germany)
    15. Delphis Pharmaceutical (India).
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.